{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:30:20Z","timestamp":1787617820542,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.arth.2025.05.105","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T11:23:33Z","timestamp":1748949813000},"page":"3221-3226.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Visceral Organ Malignancy in Patients Undergoing Primary Total Hip Arthroplasty: Is There a Role for Aspirin Prophylaxis?"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3866-4657","authenticated-orcid":false,"given":"Saad","family":"Tarabichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens T.","family":"Verhey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Brinkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rigel P.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Lebens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Deckey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Spangehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2025.05.105_bib1","first-page":"1487","article-title":"Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002","volume":"87","author":"Kurtz","year":"2005","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.arth.2009.07.021","article-title":"Venous thromboembolism","volume":"25","author":"Markel","year":"2010","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.05.105_bib5","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.arth.2016.03.031","article-title":"Aspirin can Be used as prophylaxis for prevention of venous thromboembolism after revision hip and knee arthroplasty","volume":"31","author":"Deirmengian","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.05.105_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.arth.2021.10.001","article-title":"Aspirin thromboprophylaxis is associated with less major bleeding events following total joint arthroplasty","volume":"37","author":"Shohat","year":"2022","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.05.105_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2106\/JBJS.16.00147","article-title":"Low-dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty","volume":"99","author":"Parvizi","year":"2017","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2106\/JBJS.18.00143","article-title":"The use of aspirin for prophylaxis against venous thromboembolism decreases mortality following primary total joint arthroplasty","volume":"101","author":"Rondon","year":"2019","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arth.2015.07.001","article-title":"Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection","volume":"30","author":"Huang","year":"2015","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.05.105_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2106\/JBJS.21.01529","article-title":"Recommendations from the ICM-VTE: hip & knee","volume":"104","author":"Delegates\u2217 TI-VH&","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1055\/s-0035-1564040","article-title":"Cancer tissue procoagulant mechanisms and the hypercoagulable state of patients with cancer","volume":"41","author":"Falanga","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.arth.2025.05.105_bib13","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2106\/JBJS.F.00235","article-title":"Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment","volume":"89","author":"Dorr","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-015-0470-0","article-title":"Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years","volume":"16","author":"Zhang","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.arth.2025.05.105_bib15","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00264-008-0659-z","article-title":"Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based study","volume":"33","author":"Memtsoudis","year":"2009","journal-title":"Int Orthop"},{"key":"10.1016\/j.arth.2025.05.105_bib16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.arth.2014.12.017","article-title":"Total joint arthroplasty in cancer patients","volume":"30","author":"Karam","year":"2015","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.05.105_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arth.2025.05.105_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2106\/JBJS.21.01108","article-title":"Recommendations from the ICM-VTE: oncology","volume":"104","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2106\/JBJS.18.00335","article-title":"Potent anticoagulation does not reduce venous thromboembolism in high-risk patients","volume":"101","author":"Tan","year":"2019","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib20","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arth.2025.05.105_bib26","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2106\/JBJS.21.00601","article-title":"Aspirin may Be a suitable prophylaxis for patients with a history of venous thromboembolism undergoing total joint arthroplasty","volume":"104","author":"Ludwick","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2106\/JBJS.23.01158","article-title":"Low-dose aspirin is the safest prophylaxis for prevention of venous thromboembolism after total knee arthroplasty across all patient risk profiles","volume":"106","author":"Lavu","year":"2024","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib27","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2106\/JBJS.22.01024","article-title":"Low-molecular-weight heparin is superior to aspirin in the prevention of thromboembolic disease: or is it?","volume":"104","author":"Parvizi","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160046","article-title":"Bleeding risk with long-term low-dose aspirin: a systematic review of observational studies","volume":"11","author":"Garc\u00eda Rodr\u00edguez","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.arth.2025.05.105_bib29","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arth.2025.05.105_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.arth.2016.02.074","article-title":"Aspirin is as effective as and safer than warfarin for patients at higher risk of venous thromboembolism undergoing total joint arthroplasty","volume":"31","author":"Huang","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.05.105_bib32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2106\/JBJS.16.01253","article-title":"Venous thromboembolism following hip and knee arthroplasty: the role of aspirin","volume":"99","author":"Parvizi","year":"2017","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2106\/JBJS.22.00562","article-title":"Optimizing use of large databases in joint arthroplasty and orthopaedics","volume":"104","author":"Browne","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.05.105_bib34","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s11999-007-0092-4","article-title":"Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty","volume":"466","author":"Sharrock","year":"2008","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2025.05.105_bib35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/01.STR.27.4.585","article-title":"Aspirin wars","volume":"27","author":"Hart","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.arth.2025.05.105_bib36","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arth.2025.05.105_bib37","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary Embolism Prevention (PEP) trial","volume":"355","year":"2000","journal-title":"Lancet"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325006205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325006205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:19:51Z","timestamp":1769041191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540325006205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0883540325006205"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2025.05.105","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visceral Organ Malignancy in Patients Undergoing Primary Total Hip Arthroplasty: Is There a Role for Aspirin Prophylaxis?","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2025.05.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}